Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2 - Related Studies

Evaluation of M40403 for the Prevention of Dose Limiting Toxicities of High Dose IL-2

This study has been suspended.

Study NCT00033956. Last updated on June 23, 2005. Information provided by MetaPhore Pharmaceuticals

Find Related Studies by Searching for the Conditions, Interventions, and Sponsors found in this study:


1	Conditions listed in this trial
		IL-2 Induced Hypotension

2	Additional conditions recognized in this trial
		Carcinoma, Renal Cell
		Hypotension

3	More general conditions related to this trial
		Adenocarcinoma
		Carcinoma
		Cardiovascular Diseases
		Kidney Diseases
		Kidney Neoplasms
		Neoplasms
		Neoplasms by Histologic Type
		Neoplasms by Site
		Neoplasms, Glandular and Epithelial
		Urogenital Neoplasms
		Urologic Diseases
		Urologic Neoplasms
		Vascular Diseases

4	Interventions listed in this trial
		M40403

5	Sponsors listed in this trial
		MetaPhore Pharmaceuticals